glp-1 programs Help Your Clients Navigate the New Medicare Bridge Program GLP-1 Drug Savings: A Complete

use as directed on pack and consult a healthcare professional if pregnant, nursing, or managing a medical condition

A typical FDA-approved regimen for pernicious anemia includes: 100 g IM/SC daily for 67 days Then every other day for 7 doses Then every 34 days for 23 weeks Followed by 100 g monthly for life Schedule follow-up and monitor progress Potassium levels should be monitored during the first 48 hours of treatment, as rapid red blood cell production may lead to hypokalemia and, rarely, sudden death

Healthcare providers generally consider this combination safe when both are dosed appropriately and kidney function remains normal

Avoid prolonged sun exposure and use sunscreen to protect your skin from harmful UV rays